Annual FCF:
-$978.00M-$4.26B(-129.83%)Summary
- As of today, VRTX annual free cash flow is -$978.00 million, with the most recent change of -$4.26 billion (-129.83%) on December 31, 2024.
- During the last 3 years, VRTX annual free cash flow has fallen by -$3.39 billion (-140.61%).
- VRTX annual free cash flow is now -124.92% below its all-time high of $3.93 billion, reached on December 31, 2022.
Performance
VRTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$1.14B+$212.20M(+22.88%)Summary
- As of today, VRTX quarterly free cash flow is $1.14 billion, with the most recent change of +$212.20 million (+22.88%) on September 30, 2025.
- Over the past year, VRTX quarterly free cash flow has dropped by -$162.50 million (-12.48%).
- VRTX quarterly free cash flow is now -12.48% below its all-time high of $1.30 billion, reached on September 30, 2024.
Performance
VRTX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$3.34B-$162.50M(-4.64%)Summary
- As of today, VRTX TTM free cash flow is $3.34 billion, with the most recent change of -$162.50 million (-4.64%) on September 30, 2025.
- Over the past year, VRTX TTM free cash flow has increased by +$4.69 billion (+346.93%).
- VRTX TTM free cash flow is now -20.64% below its all-time high of $4.21 billion, reached on September 30, 2023.
Performance
VRTX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VRTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -129.8% | -12.5% | +346.9% |
| 3Y3 Years | -140.6% | +26.4% | -12.5% |
| 5Y5 Years | -165.5% | +55.5% | +12.0% |
VRTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -124.9% | at low | -12.5% | +129.8% | -20.6% | +334.1% |
| 5Y | 5-Year | -124.9% | at low | -12.5% | +129.8% | -20.6% | +334.1% |
| All-Time | All-Time | -124.9% | at low | -12.5% | +129.8% | -20.6% | +334.1% |
VRTX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.14B(+22.9%) | $3.34B(-4.6%) |
| Jun 2025 | - | $927.40M(+19.2%) | $3.50B(+378.2%) |
| Mar 2025 | - | $778.20M(+58.2%) | -$1.26B(-28.6%) |
| Dec 2024 | -$978.00M(-129.8%) | $492.00M(-62.2%) | -$978.00M(+27.6%) |
| Sep 2024 | - | $1.30B(+134.0%) | -$1.35B(+5.2%) |
| Jun 2024 | - | -$3.83B(-462.0%) | -$1.43B(-141.0%) |
| Mar 2024 | - | $1.06B(+793.0%) | $3.48B(+6.1%) |
| Dec 2023 | $3.28B(-16.5%) | $118.50M(-90.3%) | $3.28B(-22.0%) |
| Sep 2023 | - | $1.23B(+14.2%) | $4.21B(+8.4%) |
| Jun 2023 | - | $1.07B(+25.3%) | $3.88B(-0.3%) |
| Mar 2023 | - | $857.80M(-17.9%) | $3.89B(-0.9%) |
| Dec 2022 | $3.93B(+63.0%) | $1.04B(+15.9%) | $3.93B(+2.9%) |
| Sep 2022 | - | $901.30M(-17.0%) | $3.81B(+0.7%) |
| Jun 2022 | - | $1.09B(+21.7%) | $3.79B(+54.5%) |
| Mar 2022 | - | $892.60M(-4.4%) | $2.45B(+1.8%) |
| Dec 2021 | $2.41B(-19.5%) | $933.28M(+6.7%) | $2.41B(+25.5%) |
| Sep 2021 | - | $874.70M(+450.4%) | $1.92B(+8.0%) |
| Jun 2021 | - | -$249.60M(-129.4%) | $1.78B(-41.7%) |
| Mar 2021 | - | $850.13M(+91.5%) | $3.05B(+1.8%) |
| Dec 2020 | $2.99B(+100.4%) | $443.84M(-39.4%) | $2.99B(+0.5%) |
| Sep 2020 | - | $732.95M(-28.2%) | $2.98B(+16.5%) |
| Jun 2020 | - | $1.02B(+28.2%) | $2.56B(+28.9%) |
| Mar 2020 | - | $796.25M(+85.5%) | $1.98B(+32.8%) |
| Dec 2019 | $1.49B(+27.2%) | $429.25M(+38.2%) | $1.49B(+9.6%) |
| Sep 2019 | - | $310.50M(-30.6%) | $1.36B(-3.5%) |
| Jun 2019 | - | $447.39M(+45.9%) | $1.41B(+12.3%) |
| Mar 2019 | - | $306.74M(+2.6%) | $1.26B(+7.1%) |
| Dec 2018 | $1.17B(+100.6%) | $298.86M(-17.1%) | $1.17B(+10.7%) |
| Sep 2018 | - | $360.44M(+23.4%) | $1.06B(+55.5%) |
| Jun 2018 | - | $292.09M(+30.8%) | $682.12M(+23.0%) |
| Mar 2018 | - | $223.38M(+20.8%) | $554.37M(-5.3%) |
| Dec 2017 | $585.52M(+226.1%) | $184.91M(+1113.0%) | $585.52M(+10.3%) |
| Sep 2017 | - | -$18.25M(-111.1%) | $530.63M(-11.7%) |
| Jun 2017 | - | $164.34M(-35.4%) | $600.73M(+30.3%) |
| Mar 2017 | - | $254.53M(+95.8%) | $461.18M(+156.9%) |
| Dec 2016 | $179.53M(+143.7%) | $130.02M(+150.8%) | $179.53M(+717.7%) |
| Sep 2016 | - | $51.84M(+109.2%) | $21.95M(+125.3%) |
| Jun 2016 | - | $24.78M(+191.4%) | -$86.69M(+60.6%) |
| Mar 2016 | - | -$27.11M(+1.6%) | -$220.11M(+46.4%) |
| Dec 2015 | -$410.73M(+27.3%) | -$27.56M(+51.5%) | -$410.73M(+21.0%) |
| Sep 2015 | - | -$56.80M(+47.7%) | -$519.97M(+7.2%) |
| Jun 2015 | - | -$108.63M(+50.1%) | -$560.11M(+5.2%) |
| Mar 2015 | - | -$217.74M(-59.2%) | -$591.10M(-4.7%) |
| Dec 2014 | -$564.64M(-448.4%) | -$136.79M(-41.1%) | -$564.64M(-36.6%) |
| Sep 2014 | - | -$96.94M(+30.6%) | -$413.47M(-18.6%) |
| Jun 2014 | - | -$139.62M(+27.0%) | -$348.76M(-64.6%) |
| Mar 2014 | - | -$191.29M(-1429.9%) | -$211.87M(-105.8%) |
| Dec 2013 | -$102.96M(-152.6%) | $14.38M(+144.6%) | -$102.96M(+1.6%) |
| Sep 2013 | - | -$32.23M(-1081.6%) | -$104.66M(-1000.4%) |
| Jun 2013 | - | -$2.73M(+96.7%) | $11.62M(-90.1%) |
| Mar 2013 | - | -$82.39M(-749.5%) | $116.94M(-40.3%) |
| Dec 2012 | $195.88M(+79.8%) | $12.68M(-84.9%) | $195.88M(-71.1%) |
| Sep 2012 | - | $84.05M(-18.1%) | $677.89M(+8.2%) |
| Jun 2012 | - | $102.59M(+3069.4%) | $626.55M(+110.6%) |
| Mar 2012 | - | -$3.46M(-100.7%) | $297.52M(+173.1%) |
| Dec 2011 | $108.96M(+116.2%) | $494.70M(+1412.1%) | $108.96M(+119.2%) |
| Sep 2011 | - | $32.72M(+114.4%) | -$566.36M(+26.8%) |
| Jun 2011 | - | -$226.43M(-17.9%) | -$773.85M(-16.1%) |
| Mar 2011 | - | -$192.02M(-6.3%) | -$666.52M(+1.2%) |
| Dec 2010 | -$674.45M(-49.5%) | -$180.62M(-3.3%) | -$674.45M(-11.7%) |
| Sep 2010 | - | -$174.78M(-46.7%) | -$603.73M(-32.6%) |
| Jun 2010 | - | -$119.10M(+40.4%) | -$455.34M(+0.8%) |
| Mar 2010 | - | -$199.95M(-81.9%) | -$458.90M(-1.7%) |
| Dec 2009 | -$451.08M(-73.9%) | -$109.91M(-316.5%) | -$451.08M(-1.3%) |
| Sep 2009 | - | -$26.39M(+78.5%) | -$445.35M(+20.0%) |
| Jun 2009 | - | -$122.65M(+36.2%) | -$556.36M(-63.6%) |
| Mar 2009 | - | -$192.14M(-84.4%) | -$340.10M(-31.1%) |
| Dec 2008 | -$259.36M | -$104.17M(+24.2%) | -$259.36M(-21.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | -$137.40M(-246.8%) | -$213.08M(-44.7%) |
| Jun 2008 | - | $93.61M(+184.0%) | -$147.25M(+54.3%) |
| Mar 2008 | - | -$111.40M(-92.4%) | -$322.35M(-13.1%) |
| Dec 2007 | -$284.89M(-419.0%) | -$57.89M(+19.1%) | -$284.89M(-19.5%) |
| Sep 2007 | - | -$71.57M(+12.2%) | -$238.31M(-230.1%) |
| Jun 2007 | - | -$81.49M(-10.2%) | -$72.18M(-19.3%) |
| Mar 2007 | - | -$73.94M(-554.1%) | -$60.51M(-10.2%) |
| Dec 2006 | -$54.89M(+71.0%) | -$11.30M(-112.0%) | -$54.89M(+1.5%) |
| Sep 2006 | - | $94.55M(+235.4%) | -$55.70M(+73.6%) |
| Jun 2006 | - | -$69.82M(-2.2%) | -$211.05M(-5.9%) |
| Mar 2006 | - | -$68.32M(-463.9%) | -$199.28M(-5.4%) |
| Dec 2005 | -$189.03M(-22.1%) | -$12.12M(+80.1%) | -$189.03M(+7.5%) |
| Sep 2005 | - | -$60.79M(-4.7%) | -$204.36M(-8.1%) |
| Jun 2005 | - | -$58.05M(+0.0%) | -$189.07M(-19.7%) |
| Mar 2005 | - | -$58.07M(-111.6%) | -$157.98M(-2.1%) |
| Dec 2004 | -$154.79M(+16.3%) | -$27.45M(+39.7%) | -$154.66M(+3.2%) |
| Sep 2004 | - | -$45.51M(-68.8%) | -$159.76M(+1.0%) |
| Jun 2004 | - | -$26.95M(+50.8%) | -$161.41M(+11.7%) |
| Mar 2004 | - | -$54.75M(-68.2%) | -$182.71M(+1.2%) |
| Dec 2003 | -$184.97M(-53.2%) | -$32.55M(+31.0%) | -$184.97M(-4.8%) |
| Sep 2003 | - | -$47.15M(+2.3%) | -$176.46M(-10.3%) |
| Jun 2003 | - | -$48.26M(+15.3%) | -$160.00M(-16.2%) |
| Mar 2003 | - | -$57.01M(-137.2%) | -$137.68M(-14.0%) |
| Dec 2002 | -$120.76M(-94.9%) | -$24.04M(+21.7%) | -$120.76M(-82.4%) |
| Sep 2002 | - | -$30.68M(-18.3%) | -$66.19M(+31.4%) |
| Jun 2002 | - | -$25.94M(+35.3%) | -$96.53M(-15.6%) |
| Mar 2002 | - | -$40.09M(-231.3%) | -$83.50M(-34.7%) |
| Dec 2001 | -$61.97M(-115.3%) | $30.53M(+150.0%) | -$61.97M(+44.7%) |
| Sep 2001 | - | -$61.03M(-372.9%) | -$112.14M(-77.9%) |
| Jun 2001 | - | -$12.90M(+30.5%) | -$63.03M(-117.9%) |
| Mar 2001 | - | -$18.57M(+5.4%) | -$28.92M(-1.3%) |
| Dec 2000 | -$28.79M(+40.0%) | -$19.63M(-64.7%) | -$28.56M(-1061.3%) |
| Sep 2000 | - | -$11.92M(-156.2%) | -$2.46M(+74.6%) |
| Jun 2000 | - | $21.20M(+216.5%) | -$9.70M(+80.2%) |
| Mar 2000 | - | -$18.20M(-381.6%) | -$48.89M(-1.8%) |
| Dec 1999 | -$48.02M(-23.3%) | $6.46M(+133.7%) | -$48.02M(+28.8%) |
| Sep 1999 | - | -$19.16M(-6.5%) | -$67.44M(-39.0%) |
| Jun 1999 | - | -$17.99M(-3.8%) | -$48.51M(-15.9%) |
| Mar 1999 | - | -$17.33M(-33.7%) | -$41.86M(-7.5%) |
| Dec 1998 | -$38.96M(-150.0%) | -$12.96M(-5611.5%) | -$38.96M(-24.1%) |
| Sep 1998 | - | -$227.00K(+98.0%) | -$31.39M(+10.5%) |
| Jun 1998 | - | -$11.34M(+21.4%) | -$35.06M(-41.3%) |
| Mar 1998 | - | -$14.42M(-167.1%) | -$24.82M(-61.2%) |
| Dec 1997 | -$15.58M(+64.8%) | -$5.40M(-38.5%) | -$15.40M(-1.3%) |
| Sep 1997 | - | -$3.90M(-254.5%) | -$15.20M(+19.1%) |
| Jun 1997 | - | -$1.10M(+78.0%) | -$18.80M(+53.5%) |
| Mar 1997 | - | -$5.00M(+3.8%) | -$40.40M(+8.8%) |
| Dec 1996 | -$44.24M(-131.7%) | -$5.20M(+30.7%) | -$44.30M(-4.2%) |
| Sep 1996 | - | -$7.50M(+67.0%) | -$42.50M(-6.0%) |
| Jun 1996 | - | -$22.70M(-155.1%) | -$40.10M(-61.7%) |
| Mar 1996 | - | -$8.90M(-161.8%) | -$24.80M(-15.9%) |
| Dec 1995 | -$19.09M(-10.5%) | -$3.40M(+33.3%) | -$21.40M(+10.1%) |
| Sep 1995 | - | -$5.10M(+31.1%) | -$23.80M(-10.2%) |
| Jun 1995 | - | -$7.40M(-34.5%) | -$21.60M(-24.9%) |
| Mar 1995 | - | -$5.50M(+5.2%) | -$17.30M(-4.2%) |
| Dec 1994 | -$17.28M(-354.7%) | -$5.80M(-100.0%) | -$16.60M(-1975.0%) |
| Sep 1994 | - | -$2.90M(+6.5%) | -$800.00K(-144.4%) |
| Jun 1994 | - | -$3.10M(+35.4%) | $1.80M(-64.7%) |
| Mar 1994 | - | -$4.80M(-148.0%) | $5.10M(-25.0%) |
| Dec 1993 | $6.79M(+203.3%) | $10.00M(+3433.3%) | $6.80M(+215.3%) |
| Sep 1993 | - | -$300.00K(-250.0%) | -$5.90M(+10.6%) |
| Jun 1993 | - | $200.00K(+106.5%) | -$6.60M(+13.2%) |
| Mar 1993 | - | -$3.10M(-14.8%) | -$7.60M(-11.8%) |
| Dec 1992 | -$6.57M(-70.6%) | -$2.70M(-170.0%) | -$6.80M(-65.9%) |
| Sep 1992 | - | -$1.00M(-25.0%) | -$4.10M(-32.3%) |
| Jun 1992 | - | -$800.00K(+65.2%) | -$3.10M(-34.8%) |
| Mar 1992 | - | -$2.30M | -$2.30M |
| Dec 1991 | -$3.85M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual free cash flow?
- What is the all-time high annual free cash flow for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual free cash flow year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly free cash flow year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM free cash flow?
- What is the all-time high TTM free cash flow for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM free cash flow year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual free cash flow?
The current annual free cash flow of VRTX is -$978.00M
What is the all-time high annual free cash flow for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual free cash flow is $3.93B
What is Vertex Pharmaceuticals Incorporated annual free cash flow year-on-year change?
Over the past year, VRTX annual free cash flow has changed by -$4.26B (-129.83%)
What is Vertex Pharmaceuticals Incorporated quarterly free cash flow?
The current quarterly free cash flow of VRTX is $1.14B
What is the all-time high quarterly free cash flow for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly free cash flow is $1.30B
What is Vertex Pharmaceuticals Incorporated quarterly free cash flow year-on-year change?
Over the past year, VRTX quarterly free cash flow has changed by -$162.50M (-12.48%)
What is Vertex Pharmaceuticals Incorporated TTM free cash flow?
The current TTM free cash flow of VRTX is $3.34B
What is the all-time high TTM free cash flow for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM free cash flow is $4.21B
What is Vertex Pharmaceuticals Incorporated TTM free cash flow year-on-year change?
Over the past year, VRTX TTM free cash flow has changed by +$4.69B (+346.93%)